M1 Kliniken AG Reports Strong Financial Growth in 2024

Berlin, April 29, 2025 - M1 Kliniken AG has disclosed its preliminary IFRS consolidated figures for the 2024 financial year. The company experienced a notable 70% rise in EBIT to EUR 26.8 million and a 57% increase in earnings per share to EUR 0.85. Group revenue grew by 7% to EUR 339.2 million, driven by sustained demand for beauty treatments and an effective efficiency strategy. The equity ratio improved from 67% to 71%, indicating strong financial stability.

The Beauty segment remains the primary growth driver, with revenue up 30% to EUR 91.7 million. The EBIT margin in this sector held stable at around 22%. Meanwhile, the Trading segment's revenue stayed consistent, yet EBIT surged to EUR 6.72 million from EUR 0.25 million the previous year.

Five new clinics were opened, enhancing M1’s market leadership in Europe and Australia. Looking forward, the company plans to continue expanding its clinic network to achieve an annual revenue target of EUR 200 to 300 million by 2029.